Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.
Identifieur interne : 004691 ( PubMed/Checkpoint ); précédent : 004690; suivant : 004692Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.
Auteurs : M J Beach [États-Unis] ; T G Streit ; D G Addiss ; R. Prospere ; J M Roberts ; P J LammieSource :
- The American journal of tropical medicine and hygiene [ 0002-9637 ] ; 1999.
Descripteurs français
- KwdFr :
- Albendazole (usage thérapeutique), Animaux, Antihelminthiques (usage thérapeutique), Ascaridiose (), Ascaridiose (traitement médicamenteux), Ascaridiose (épidémiologie), Association de médicaments, Enfant, Enfant d'âge préscolaire, Femelle, Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Haïti (épidémiologie), Helminthiase (), Helminthiase (traitement médicamenteux), Helminthiase (épidémiologie), Humains, Infections à ankylostomes (), Infections à ankylostomes (traitement médicamenteux), Infections à ankylostomes (épidémiologie), Ivermectine (usage thérapeutique), Mâle, Méthode en double aveugle, Parasitoses intestinales (), Parasitoses intestinales (traitement médicamenteux), Parasitoses intestinales (épidémiologie), Prévalence, Taille, Trichocéphalose (), Trichocéphalose (traitement médicamenteux), Trichocéphalose (épidémiologie), Wuchereria bancrofti (), Évaluation de l'état nutritionnel.
- MESH :
- traitement médicamenteux : Ascaridiose, Filariose lymphatique, Helminthiase, Infections à ankylostomes, Parasitoses intestinales, Trichocéphalose.
- usage thérapeutique : Albendazole, Antihelminthiques, Ivermectine.
- épidémiologie : Ascaridiose, Filariose lymphatique, Haïti, Helminthiase, Infections à ankylostomes, Parasitoses intestinales, Trichocéphalose.
- Animaux, Ascaridiose, Association de médicaments, Enfant, Enfant d'âge préscolaire, Femelle, Filariose lymphatique, Helminthiase, Humains, Infections à ankylostomes, Mâle, Méthode en double aveugle, Parasitoses intestinales, Prévalence, Taille, Trichocéphalose, Wuchereria bancrofti, Évaluation de l'état nutritionnel.
- Wicri :
- geographic : Haïti.
English descriptors
- KwdEn :
- Albendazole (therapeutic use), Animals, Anthelmintics (therapeutic use), Ascariasis (drug therapy), Ascariasis (epidemiology), Ascariasis (prevention & control), Body Height, Child, Child, Preschool, Double-Blind Method, Drug Therapy, Combination, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Female, Haiti (epidemiology), Helminthiasis (drug therapy), Helminthiasis (epidemiology), Helminthiasis (prevention & control), Hookworm Infections (drug therapy), Hookworm Infections (epidemiology), Hookworm Infections (prevention & control), Humans, Intestinal Diseases, Parasitic (drug therapy), Intestinal Diseases, Parasitic (epidemiology), Intestinal Diseases, Parasitic (prevention & control), Ivermectin (therapeutic use), Male, Nutrition Assessment, Prevalence, Trichuriasis (drug therapy), Trichuriasis (epidemiology), Trichuriasis (prevention & control), Wuchereria bancrofti (drug effects).
- MESH :
- chemical , therapeutic use : Albendazole, Anthelmintics, Ivermectin.
- geographic , epidemiology : Haiti.
- drug effects : Wuchereria bancrofti.
- drug therapy : Ascariasis, Elephantiasis, Filarial, Helminthiasis, Hookworm Infections, Intestinal Diseases, Parasitic, Trichuriasis.
- epidemiology : Ascariasis, Elephantiasis, Filarial, Helminthiasis, Hookworm Infections, Intestinal Diseases, Parasitic, Trichuriasis.
- prevention & control : Ascariasis, Elephantiasis, Filarial, Helminthiasis, Hookworm Infections, Intestinal Diseases, Parasitic, Trichuriasis.
- Animals, Body Height, Child, Child, Preschool, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Nutrition Assessment, Prevalence.
Abstract
This randomized, placebo-controlled trial investigated the efficacy and nutritional benefit of combining chemotherapeutic treatment for intestinal helminths (albendazole) and lymphatic filariasis (ivermectin). Children were infected with Ascaris (29.2%), Trichuris (42.2%), and hookworm (6.9%), with 54.7% of children having one or more of these parasites. Wuchereria bancrofti microfilaria were found in 13.3% of the children. Children were randomly assigned to treatment with placebo, albendazole, ivermectin, or combined therapy. Combination treatment reduced the prevalence of Trichuris infections significantly more than either drug alone. Combination therapy also significantly reduced the prevalence and density of W. bancrofti microfilaremia compared with placebo or ivermectin alone. Only combination therapy resulted in significantly greater gains in height (hookworm-infected children) or weight (Trichuris-infected children) compared with the placebo group. Combined albendazole and ivermectin was a more efficacious treatment for intestinal helminth and W. bancrofti infections in children and resulted in nutritional benefits not found with either drug alone.
PubMed: 10466981
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:10466981Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.</title><author><name sortKey="Beach, M J" sort="Beach, M J" uniqKey="Beach M" first="M J" last="Beach">M J Beach</name><affiliation wicri:level="1"><nlm:affiliation>Division of Parasitic Diseases, National Center for Infectious Diseases and Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Parasitic Diseases, National Center for Infectious Diseases and Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724</wicri:regionArea><wicri:noRegion>Georgia 30341-3724</wicri:noRegion></affiliation></author><author><name sortKey="Streit, T G" sort="Streit, T G" uniqKey="Streit T" first="T G" last="Streit">T G Streit</name></author><author><name sortKey="Addiss, D G" sort="Addiss, D G" uniqKey="Addiss D" first="D G" last="Addiss">D G Addiss</name></author><author><name sortKey="Prospere, R" sort="Prospere, R" uniqKey="Prospere R" first="R" last="Prospere">R. Prospere</name></author><author><name sortKey="Roberts, J M" sort="Roberts, J M" uniqKey="Roberts J" first="J M" last="Roberts">J M Roberts</name></author><author><name sortKey="Lammie, P J" sort="Lammie, P J" uniqKey="Lammie P" first="P J" last="Lammie">P J Lammie</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1999">1999</date><idno type="RBID">pubmed:10466981</idno><idno type="pmid">10466981</idno><idno type="wicri:Area/PubMed/Corpus">004C13</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004C13</idno><idno type="wicri:Area/PubMed/Curation">004C13</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004C13</idno><idno type="wicri:Area/PubMed/Checkpoint">004C13</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004C13</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.</title><author><name sortKey="Beach, M J" sort="Beach, M J" uniqKey="Beach M" first="M J" last="Beach">M J Beach</name><affiliation wicri:level="1"><nlm:affiliation>Division of Parasitic Diseases, National Center for Infectious Diseases and Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Parasitic Diseases, National Center for Infectious Diseases and Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724</wicri:regionArea><wicri:noRegion>Georgia 30341-3724</wicri:noRegion></affiliation></author><author><name sortKey="Streit, T G" sort="Streit, T G" uniqKey="Streit T" first="T G" last="Streit">T G Streit</name></author><author><name sortKey="Addiss, D G" sort="Addiss, D G" uniqKey="Addiss D" first="D G" last="Addiss">D G Addiss</name></author><author><name sortKey="Prospere, R" sort="Prospere, R" uniqKey="Prospere R" first="R" last="Prospere">R. Prospere</name></author><author><name sortKey="Roberts, J M" sort="Roberts, J M" uniqKey="Roberts J" first="J M" last="Roberts">J M Roberts</name></author><author><name sortKey="Lammie, P J" sort="Lammie, P J" uniqKey="Lammie P" first="P J" last="Lammie">P J Lammie</name></author></analytic><series><title level="j">The American journal of tropical medicine and hygiene</title><idno type="ISSN">0002-9637</idno><imprint><date when="1999" type="published">1999</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (therapeutic use)</term><term>Animals</term><term>Anthelmintics (therapeutic use)</term><term>Ascariasis (drug therapy)</term><term>Ascariasis (epidemiology)</term><term>Ascariasis (prevention & control)</term><term>Body Height</term><term>Child</term><term>Child, Preschool</term><term>Double-Blind Method</term><term>Drug Therapy, Combination</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Female</term><term>Haiti (epidemiology)</term><term>Helminthiasis (drug therapy)</term><term>Helminthiasis (epidemiology)</term><term>Helminthiasis (prevention & control)</term><term>Hookworm Infections (drug therapy)</term><term>Hookworm Infections (epidemiology)</term><term>Hookworm Infections (prevention & control)</term><term>Humans</term><term>Intestinal Diseases, Parasitic (drug therapy)</term><term>Intestinal Diseases, Parasitic (epidemiology)</term><term>Intestinal Diseases, Parasitic (prevention & control)</term><term>Ivermectin (therapeutic use)</term><term>Male</term><term>Nutrition Assessment</term><term>Prevalence</term><term>Trichuriasis (drug therapy)</term><term>Trichuriasis (epidemiology)</term><term>Trichuriasis (prevention & control)</term><term>Wuchereria bancrofti (drug effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Albendazole (usage thérapeutique)</term><term>Animaux</term><term>Antihelminthiques (usage thérapeutique)</term><term>Ascaridiose ()</term><term>Ascaridiose (traitement médicamenteux)</term><term>Ascaridiose (épidémiologie)</term><term>Association de médicaments</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Haïti (épidémiologie)</term><term>Helminthiase ()</term><term>Helminthiase (traitement médicamenteux)</term><term>Helminthiase (épidémiologie)</term><term>Humains</term><term>Infections à ankylostomes ()</term><term>Infections à ankylostomes (traitement médicamenteux)</term><term>Infections à ankylostomes (épidémiologie)</term><term>Ivermectine (usage thérapeutique)</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Parasitoses intestinales ()</term><term>Parasitoses intestinales (traitement médicamenteux)</term><term>Parasitoses intestinales (épidémiologie)</term><term>Prévalence</term><term>Taille</term><term>Trichocéphalose ()</term><term>Trichocéphalose (traitement médicamenteux)</term><term>Trichocéphalose (épidémiologie)</term><term>Wuchereria bancrofti ()</term><term>Évaluation de l'état nutritionnel</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term><term>Anthelmintics</term><term>Ivermectin</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Haiti</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Ascariasis</term><term>Elephantiasis, Filarial</term><term>Helminthiasis</term><term>Hookworm Infections</term><term>Intestinal Diseases, Parasitic</term><term>Trichuriasis</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Ascariasis</term><term>Elephantiasis, Filarial</term><term>Helminthiasis</term><term>Hookworm Infections</term><term>Intestinal Diseases, Parasitic</term><term>Trichuriasis</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Ascariasis</term><term>Elephantiasis, Filarial</term><term>Helminthiasis</term><term>Hookworm Infections</term><term>Intestinal Diseases, Parasitic</term><term>Trichuriasis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Ascaridiose</term><term>Filariose lymphatique</term><term>Helminthiase</term><term>Infections à ankylostomes</term><term>Parasitoses intestinales</term><term>Trichocéphalose</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term><term>Antihelminthiques</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ascaridiose</term><term>Filariose lymphatique</term><term>Haïti</term><term>Helminthiase</term><term>Infections à ankylostomes</term><term>Parasitoses intestinales</term><term>Trichocéphalose</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Body Height</term><term>Child</term><term>Child, Preschool</term><term>Double-Blind Method</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Male</term><term>Nutrition Assessment</term><term>Prevalence</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Ascaridiose</term><term>Association de médicaments</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Filariose lymphatique</term><term>Helminthiase</term><term>Humains</term><term>Infections à ankylostomes</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Parasitoses intestinales</term><term>Prévalence</term><term>Taille</term><term>Trichocéphalose</term><term>Wuchereria bancrofti</term><term>Évaluation de l'état nutritionnel</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Haïti</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This randomized, placebo-controlled trial investigated the efficacy and nutritional benefit of combining chemotherapeutic treatment for intestinal helminths (albendazole) and lymphatic filariasis (ivermectin). Children were infected with Ascaris (29.2%), Trichuris (42.2%), and hookworm (6.9%), with 54.7% of children having one or more of these parasites. Wuchereria bancrofti microfilaria were found in 13.3% of the children. Children were randomly assigned to treatment with placebo, albendazole, ivermectin, or combined therapy. Combination treatment reduced the prevalence of Trichuris infections significantly more than either drug alone. Combination therapy also significantly reduced the prevalence and density of W. bancrofti microfilaremia compared with placebo or ivermectin alone. Only combination therapy resulted in significantly greater gains in height (hookworm-infected children) or weight (Trichuris-infected children) compared with the placebo group. Combined albendazole and ivermectin was a more efficacious treatment for intestinal helminth and W. bancrofti infections in children and resulted in nutritional benefits not found with either drug alone.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10466981</PMID><DateCreated><Year>1999</Year><Month>09</Month><Day>15</Day></DateCreated><DateCompleted><Year>1999</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-9637</ISSN><JournalIssue CitedMedium="Print"><Volume>60</Volume><Issue>3</Issue><PubDate><Year>1999</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The American journal of tropical medicine and hygiene</Title><ISOAbbreviation>Am. J. Trop. Med. Hyg.</ISOAbbreviation></Journal><ArticleTitle>Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.</ArticleTitle><Pagination><MedlinePgn>479-86</MedlinePgn></Pagination><Abstract><AbstractText>This randomized, placebo-controlled trial investigated the efficacy and nutritional benefit of combining chemotherapeutic treatment for intestinal helminths (albendazole) and lymphatic filariasis (ivermectin). Children were infected with Ascaris (29.2%), Trichuris (42.2%), and hookworm (6.9%), with 54.7% of children having one or more of these parasites. Wuchereria bancrofti microfilaria were found in 13.3% of the children. Children were randomly assigned to treatment with placebo, albendazole, ivermectin, or combined therapy. Combination treatment reduced the prevalence of Trichuris infections significantly more than either drug alone. Combination therapy also significantly reduced the prevalence and density of W. bancrofti microfilaremia compared with placebo or ivermectin alone. Only combination therapy resulted in significantly greater gains in height (hookworm-infected children) or weight (Trichuris-infected children) compared with the placebo group. Combined albendazole and ivermectin was a more efficacious treatment for intestinal helminth and W. bancrofti infections in children and resulted in nutritional benefits not found with either drug alone.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beach</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Parasitic Diseases, National Center for Infectious Diseases and Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Streit</LastName><ForeName>T G</ForeName><Initials>TG</Initials></Author><Author ValidYN="Y"><LastName>Addiss</LastName><ForeName>D G</ForeName><Initials>DG</Initials></Author><Author ValidYN="Y"><LastName>Prospere</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Lammie</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Trop Med Hyg</MedlineTA><NlmUniqueID>0370507</NlmUniqueID><ISSNLinking>0002-9637</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000871">Anthelmintics</NameOfSubstance></Chemical><Chemical><RegistryNumber>70288-86-7</RegistryNumber><NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>F4216019LN</RegistryNumber><NameOfSubstance UI="D015766">Albendazole</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000871" MajorTopicYN="N">Anthelmintics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001196" MajorTopicYN="N">Ascariasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001827" MajorTopicYN="N">Body Height</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006205" MajorTopicYN="N" Type="Geographic">Haiti</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006373" MajorTopicYN="N">Helminthiasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006725" MajorTopicYN="N">Hookworm Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007411" MajorTopicYN="N">Intestinal Diseases, Parasitic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015596" MajorTopicYN="N">Nutrition Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014257" MajorTopicYN="N">Trichuriasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014958" MajorTopicYN="N">Wuchereria bancrofti</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>8</Month><Day>31</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>8</Month><Day>31</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10466981</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Addiss, D G" sort="Addiss, D G" uniqKey="Addiss D" first="D G" last="Addiss">D G Addiss</name><name sortKey="Lammie, P J" sort="Lammie, P J" uniqKey="Lammie P" first="P J" last="Lammie">P J Lammie</name><name sortKey="Prospere, R" sort="Prospere, R" uniqKey="Prospere R" first="R" last="Prospere">R. Prospere</name><name sortKey="Roberts, J M" sort="Roberts, J M" uniqKey="Roberts J" first="J M" last="Roberts">J M Roberts</name><name sortKey="Streit, T G" sort="Streit, T G" uniqKey="Streit T" first="T G" last="Streit">T G Streit</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Beach, M J" sort="Beach, M J" uniqKey="Beach M" first="M J" last="Beach">M J Beach</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004691 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 004691 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:10466981
|texte= Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:10466981" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |